Log in to save to my catalogue

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assem...

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assem...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3b23585f88cb4b29866249912e9885cc

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly

About this item

Full title

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-08, Vol.13 (1), p.5004-5004, Article 5004

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Amyloid self-assembly is linked to numerous devastating cell-degenerative diseases. However, designing inhibitors of this pathogenic process remains a major challenge. Cross-interactions between amyloid-β peptide (Aβ) and islet amyloid polypeptide (IAPP), key polypeptides of Alzheimer’s disease (AD) and type 2 diabetes (T2D), have been suggested to...

Alternative Titles

Full title

Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3b23585f88cb4b29866249912e9885cc

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3b23585f88cb4b29866249912e9885cc

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-32688-0

How to access this item